1. Advances in Diagnosis and Therapy for Bladder Cancer
   Xinzi Hu et al, 2022, Cancers CrossRef
2. The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
   Weitao Zheng et al, 2022, Diagnostics CrossRef
3. Urine Cytology
   David G. Bostwick, 2020, Urologic Surgical Pathology CrossRef
4. A comprehensive comparison of fluorescence in situ hybridization and cytology for the detection of upper urinary tract urothelial carcinoma
   Hongyu Jin et al, 2018, Medicine CrossRef
5. Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria
   Ilaria Lucca et al, 2019, Oncology Letters CrossRef
6. Surveillance of non-muscle invasive bladder cancer using fluorescence in situ hybridization
   Tianhai Lin et al, 2019, Medicine CrossRef
7. Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis
   Amir Hossein Aalami et al, 2022, International Journal of Clinical Oncology CrossRef
8. Non‐invasive diagnosis and surveillance of bladder cancer with driver and passenger DNA methylation in a prospective cohort study
   Yu Xiao et al, 2022, Clinical and Translational Medicine CrossRef
9. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer
   Xu Chen et al, 2020, Journal of Clinical Investigation CrossRef
10. Exosomes in urological diseases - Biological functions and clinical applications
    Qiang Song et al, 2022, Cancer Letters CrossRef
11. UCseek: ultrasensitive early detection and recurrence monitoring of urothelial carcinoma by shallow-depth genome-wide bisulfite sequencing of urinary sediment DNA
    Ping Wang et al, 2023, eBioMedicine CrossRef
12. Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional study
    Junjiong Zheng et al, 2023, Journal of Translational Medicine CrossRef
13. Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma
    Xiaopeng Mao et al, 2018, Oncology Letters CrossRef
14. Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis
    Huitao Wang et al, 2019, BMC Urology CrossRef
15. Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer
    Ildikó Kocsmár et al, 2020, American Journal of Clinical Pathology CrossRef
16. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study
    Run-Qi Guo et al, 2018, Urologic Oncology: Seminars and Original Investigations CrossRef
17. Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population
    Liqun Zhou et al, 2019, Asian Journal of Urology CrossRef
18. Non-Invasive Biomarkers in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma—A Systematic Review
    Łukasz Białek et al, 2022, Cancers CrossRef